Get started
Work

Challenges of equitable access to device-aided therapies for advanced Parkinson’s Disease in Poland — expert consensus and treatment recommendations

Year: 2024
Type: article
Abstract: INTRODUCTION: In Poland, not all forms of device-aided therapies for advanced Parkinson's Disease (APD) are currently available. MATERIAL AND METHODS: We aimed to produce a consensus recommendation from Polish movement disorders experts after discussing gaps in the APD care pathway in Poland. RESULTS: Rescue therapy with apomorphine (APO) PEN injection and levodopa-entacapone-carbidopa intestinal gel infusion are not included in Poland's Specialist Therapeutic Programme, and are thus not reimbursed. For APO infusion, only the medication is reimbursed but not the device. CONCLUSIONS: Consensus expert opinion is that APD patients in Poland would benefit from additional reimbursement access to these treatment options to improve APD patient care.
DOI: 10.5603/pjnns.102680
Authors: Karolina Popławska-Domaszewicz, Joanna Siuda, Monika Rudzińska-Bar, Slawomir Budrewicz, Dariusz Koziorowski, Andrzej Bogucki, K. Ray Chaudhuri, Jarosław Sławek
Institutions: Poznan University of Medical Sciences, King's College Hospital, Medical University of Silesia, Andrzej Frycz Modrzewski Krakow University, University of Wrocław, Wroclaw Medical University, Medical University of Warsaw, Medical University of Lodz, Gdańsk Medical University
Language: English
Subfield: Neurology
Field: Medicine
Open Access status: bronze
Funders: Biogen, Wellcome Trust, Parkinson's Foundation, National Institute for Health and Care Research, Parkinson's UK, EVER Neuro Pharma, Wörwag Pharma, Britannia Pharmaceuticals, Medical Research Council
OpenAlex ID: W4405835913
FWCI: 0.915
Cites: 34
Cited by: 4
Related to: 10